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Abstract
Background: Randomised controlled trials guard against selection bias and therefore offer the fairest way of
evaluating healthcare interventions such as medicinal products, devices and services. Recruitment to trials can
be extremely difficult, and poor recruitment can lead to extensions to both time and budget and may result in
an underpowered study which does not satisfactorily answer the original research question. In the worst cases, a
trial may be abandoned, causing huge waste. The evidence to support the choice of recruitment interventions is
currently weak. Non-randomised evaluations of recruitment interventions are currently rejected on grounds of poor
methodological quality, but systematic evaluation and assessment of this substantial body of work (using Grading of
Recommendations Assessment, Development and Evaluation (GRADE) where possible) may provide useful information
to support and inform the recruitment decisions of trialists and the research priorities of methodology researchers.
Methods: The following databases will be searched for relevant studies: Cochrane Methodology Register,
MEDLINE, EMBASE, CINAHL and PsycINFO. Any non-randomised study that includes a comparison of two or
more interventions to improve recruitment to randomised controlled trials will be included. We will not apply
any restrictions on publication date, language or journal. The primary outcome will be the number of individuals or
centres recruited into a randomised controlled trial. The secondary outcome will be cost per recruit. Two reviewers will
independently screen abstracts for eligible studies, and then, full texts of potentially relevant records will be reviewed.
Disagreements will be resolved through discussion. The methodological quality of studies will be assessed using the
Cochrane risk of bias tool for non-randomised studies, and the GRADE system will be used if studies are pooled.
Discussion: This review aims to summarise the evidence on methods used to improve recruitment to randomised
controlled trials. Carrying out a systematic review including only data from non-randomised studies is a novel
approach, and one which some may argue is futile. However, we believe that the systematic evaluation of what
is likely to be a substantial amount of research activity is necessary, worthwhile, and will yield valuable results for
the clinical trials community regardless of whether the outcomes find in favour of one or more interventions.
Should the results of this review suggest that non-randomised evaluations do have something to offer trialists
planning their recruitment strategies, the review may be combined in the future with the Cochrane review
of randomised evaluations to produce a full review of recruitment strategies encompassing both randomised and
non-randomised evaluation methods.
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Background
There is a peculiar paradox that exists in trial
execution – we perform clinical trials to generate
evidence to improve patient outcomes; however, we
conduct clinical trials like anecdotal medicine: (1) we
do what we think works; (2) we rely on experience
and judgement and (3) limited data to support best
practices [1].
Randomised controlled trials (RCTs) are at the core of
evidence-based healthcare. They guard against selection
bias and therefore offer the fairest way of evaluating
healthcare interventions [2], whether these involve medi-
cinal products, devices or services. Recruitment of both
clinicians and participants to RCTs can be extremely
difficult.
If recruitment fails to successfully reach target sample
size of the trial, the trial may be deemed ‘underpowered’.
Underpowered trials raise an important ethical question;
participants have voluntarily taken part, they have been
exposed to an intervention with unknown or uncertain
benefit based on the premise that they are doing so for
good reason, and yet, there is now the possibility that
the research question will remain unanswered even after
the trial has been completed.
The issue of poor recruitment is widespread; anecdotal
evidence tells us it is often the most frustrating stage in
the trial process, while more rigorous evidence suggests
that <50 % of trials meet their recruitment target or
meet their target without an extension [3–7]. More
recent research has also highlighted the problem of fre-
quent extensions to recruitment time. An examination
of recruitment into trials taking place between 2002 and
2008 and funded by two of the largest funding bodies in
the UK, the National Institute of Health Research
(NIHR)’s Health Technology Assessment (HTA)
programme and the UK Medical Research Council
(MRC) [8], found that 45 % of trials received an exten-
sion of some kind, and these were no more likely to
reach recruitment targets than those not receiving
extensions.
This systematic review builds on the current
Cochrane systematic review of interventions to im-
prove trial recruitment [9] but with one substantial
difference. Until now, systematic review of non-
randomised studies of recruitment interventions has
been largely rejected on the grounds that the evi-
dence these studies provide with regard to interven-
tion effect is of low quality. Carrying out a systematic
review including only data from non-randomised
studies is a novel approach, and one which some may
argue is futile because of the low methodological
quality of these studies for measuring effect. However,
we believe that the systematic evaluation of what is
likely to be a substantial amount of research activity
is necessary (because without collation, it is currently
ignored), worthwhile (because there may be substan-
tial/promising undiscovered effects), and will yield
valuable results for the clinical trials community re-
gardless of whether the outcomes find in favour of
one or more interventions. Moreover, we will use the
Grading of Recommendations Assessment, Develop-
ment and Evaluation (GRADE) [10] system of rating
confidence in cumulative estimates, which means that
non-randomised studies (typically viewed as low or
very low quality) could have their quality rating in-
creased if the aggregated data show large effects, a
dose response or if all plausible confounders would
have reduced the effect. This provides the potential
for evidence from non-randomised studies to supple-
ment RCT evidence, which is currently limited and
often of low quality: only 12 of 45 included studies in
the Cochrane recruitment review are considered to be
at low risk of bias.
It is possible that our systematic and considered evalu-
ation of this substantial body of research activity finds
that it has little or no utility, in which case we will be in
a strong position to recommend to funders and others
that researchers stop designing, conducting and report-
ing such studies and spend their scarce resources doing
something more beneficial.
What will we know after doing the review that we do
not know now?
The Cochrane review of randomised evaluations of
recruitment interventions has rejected dozens of non-
randomised studies of recruitment interventions, mean-
ing there is currently an untapped body of evidence that
may help trialists make more evidence-based decisions
about recruitment. Our review has the potential to de-
liver one of two results:
1. Collated non-randomised data provide help to
trialists through two mechanisms:
(a)At least some non-randomised studies can be
pooled and their results are such that the GRADE
rating for this body of evidence can be increased.
(b)Trends in effect may suggest interventions
worthy of more rigorous randomised evaluations.
2. Alternatively, the collated data from non-
randomised studies remains of ‘low’ or ‘very low’
quality, displays no clear trends and is therefore of
no use to trialists planning their recruitment
strategies.
Both results would move the field forward.
Should we find result 1, we will open up a previ-
ously overlooked evidence base that trialists can use
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to inform their trial recruitment decisions. The nature
of interventions tested using non-randomised studies
is unclear, so there is a real possibility that we may
reveal completely new, effective interventions which
can considered by trialists. In the case of known re-
cruitment strategies, we may uncover data that adds
weight to existing interventions previously investi-
gated through the use of RCTs. This would
strengthen our current knowledge base. Some SMS-
based interventions, for example, may fall into this
category.
There is also the possibility that grouping of non-
randomised studies may reveal encouraging trends,
but methodological weaknesses do not allow for the
GRADE rating to be raised. In this case, the work
would suggest that these particular interventions are
worthy of evaluation in an RCT, addressing current
gaps in evidence. The subsequent use of well-
designed RCTs would provide high-quality evidence
to support or refute the suggested trend from the
non-randomised studies. Moreover, the protocols for
such RCTs could be published as Studies Within A
Trial (SWATs) [11], meaning that trialists and others
(including funders) have easy access to a database of
recruitment interventions in need of evaluation.
Finally, if we find result 1, we will discuss approaches
to combining this review with the current Cochrane
review of randomised evaluations of interventions to
improve recruitment to trials (which ST leads) [9]
with the Cochrane Methodology Review Group.
Should we find result 2, meaning that the data
demonstrate consistently low quality with no evident
trends, we will be able to say that there is very little
point in continuing to invest our time, energy or
money as a research community, in doing (and
publishing) these non-randomised studies, which
would then represent a recurring example of
research waste.
Why should non-randomised evaluations of recruit-
ment strategies be reviewed separately to the existing
Cochrane review of randomised evaluations of recruit-
ment strategies?
This review of non-randomised evaluations may
provide little evidence of immediate use to trialists,
despite a large number of included studies. As dis-
cussed previously, one possible use of this review is
to make clear that non-randomised evaluations of re-
cruitment interventions are of little use. Given this,
and the length of time a combined review would take,
it is prudent to deal with the non-randomised evi-
dence separately to begin with. The two reviews may
be combined at a later date, and the overlap in
author teams means that this review can be com-
pleted with an eye on this.
Objectives
The objective of this study is to quantify the effects of
strategies to improve recruitment of participants to
RCTs evaluated using non-randomised designs.
Methods
Types of studies
Non-randomised studies include a comparison of two or
more interventions to improve recruitment to rando-
mised controlled trials. We define ‘non-randomised
studies’ as any quantitative study estimating the effect-
iveness of a recruitment intervention that did not use
randomisation to allocate participants to intervention or
comparison groups. These types of studies are referred
to by multiple names in the literature including but not
limited to observational studies, cohort studies and case-
control studies.
Studies covering questionnaire response and studies of
retention strategies will be excluded on the grounds that
these are separate issues addressed by their correspond-
ing Cochrane Methodology reviews [12, 13].
Participants
Individuals involved in a trial. The context of the trial is
likely to be healthcare but may not be, for the reason
that interventions that are effective in other fields may
also be applicable to settings in the healthcare environ-
ment. Strategies evaluated within simulated trials (stud-
ies that ask potential participants whether they would
take part in a trial if it was to be run but the study does
not run the trial) will not be eligible.
Types of intervention
Any intervention or approach aimed at improving or
supporting recruitment of participants nested within
studies performed for purposes unrelated to recruitment.
Included interventions could be wide-ranging, aimed at
research ethics committees (e.g. interventions support-
ing the case for non-requirement of mandatory signed
and witnessed consent for recruitment to a trial), collab-
orators (e.g. healthcare professionals recruiting patients
for a trial) or study participants (e.g. patients being ran-
domised to a trial). Examples of such interventions are
the use of SMS appointment reminders for participants
supplying a mobile telephone number, use of news-
paper or social media advertising, a dedicated email
address or a toll-free telephone number as the initial
point of contact from interested participants, simpli-
fied consent procedures for participants within a
particular age range and recruitment coordinators
working at selected trial sites.
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Types of comparator
Any approach aimed at improving or supporting recruit-
ment of participants nested within studies performed for
purposes unrelated to recruitment. Examples are as
given in the ‘Types of intervention’ section. The com-
parator could also be nothing, meaning the intervention
is compared against taking no special measures to im-
prove recruitment.
Types of outcome measures
Primary: Number of individuals or centres recruited into
a randomised controlled trial.
Secondary: Cost of using the recruitment intervention
per recruit.
Search methods for identification of studies
The search strategy was developed by an Information
Specialist (CF), who has expertise in developing
search strategies for health technology assessment, es-
pecially through being the Information Specialist at-
tached to the Aberdeen-based National Institute of
Health Research Technology Assessment Review
Group (http://www.nets.nihr.ac.uk/programmes/hta/po
licy-makers/tar-teams). The strategy was reviewed by
the other authors. To identify studies, we will search
bibliographic databases and hand-search reference
lists of both relevant systematic reviews and all in-
cluded studies. We will search systematic reviews of
randomised recruitment interventions (e.g. [9]) for
studies that were excluded on the grounds that they
were not randomised.
We will apply neither language nor time restriction.
We will search the following databases:
Cochrane Methodology Register (CMR)
Medical Literature Analysis and Retrieval System
Online (MEDLINE), OVID 1946 to present
MEDLINE In-Process, OVID current
Excerpta Medica dataBASE (EMBASE), OVID 1947 to
present
Cumulative Index to Nursing and Allied Health
Literature (CINAHL), EBSCO 1981 to present
PsycINFO, Ovid 1967 to present
The following multifile search strategy for MEDLINE
and EMBASE (OVID) will be adapted for the other data-
bases listed.
1 *Patient selection/
2 *informed consent/
3 ((participat$ or recruit$ or enter$) adj4 (trial? or
research or study or studies or random$)).tw.
4 (participat$ adj4 (recruit$ or decide$ or decision or
agree$ or consent$)).tw.
5 1 or 2 or 3 or 4
6 exp *clinical trials as topic/use prmz
7 exp *“clinical trial (topic)”/use emcz
8 *research subjects/use prmz
9 *research subject/use emcz
10 recruit$.ti.
11 informed consent.ti.
12 (recruit$ adj7 (trial? or research or study or
studies)).ti.
13 (participa$ adj7 (trial? or research or study or
studies)).ti.
14 or/6–13
15 5 and 14
16 controlled clinical trial.pt. use prmz
17 controlled clinical trial/use emcz
18 intervention studies/
19 randomized controlled trials as topic/use prmz
20 “randomized controlled trial (topic)”/
21 experiment$.tw.
22 quasi-experimental study/ use emcz
23 impact.tw.
24 intervention?.tw.
25 chang$.tw.
26 evaluation studies/
27 evaluat$.tw.
28 effect$.tw.
29 examin$.tw
30 compar$.tw.
31 comparative studies/
32 or/16–31
33 exp animals/ not humans/
34 32 not 33
35 15 and 34
36 35 not (randomized controlled trial.pt. or
randomi?ed.ti.
37 36 not randomized controlled trial/use emcz
38 37 not (letter or editorial or comment or
abstract).pt.
Data management
All search results will be merged into the reference man-
agement software EndNote, and duplicate records of the
same report will be removed using the EndNote de-
duplication tool. We will use a master spreadsheet to
track all inclusions/exclusions, which will allow us to
create a Preferred Reporting Items for Systematic Re-
views and Meta-Analyses (PRISMA) flow diagram once
the screening process is complete (Additional file 1).
Extracted data will be collected on specially designed
forms (see ‘Data extraction’ section) and data entered
into Cochrane RevMan tool (http://tech.cochrane.org/
revman) when the data make this possible.
Identifying studies
Two authors will independently screen the titles and
abstracts of all records retrieved from searches of the
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electronic bibliographic databases stated above. The
full text will be acquired for studies that look as if
they meet the inclusion criteria. The full texts of all
potentially eligible studies will be independently
reviewed by two authors to determine if they meet
the stated inclusion criteria. We will seek additional
information from study authors where necessary to
resolve questions about eligibility and provide other
data as required. Any disagreements throughout the
process of trial identification and selection will be
resolved through discussion and, if necessary, the
involvement of a third reviewer.
Risk of bias of individual studies
As we are using non-randomised studies only, the likeli-
hood of increased heterogeneity resulting from residual
confounding is heightened. The Risk Of Bias In Non-
randomized Studies - of Interventions (ROBINS-I; https://
sites.google.com/site/riskofbiastool/) will be used to assess
the risk of bias due to confounding. Aspects of methodo-
logical quality such as participant selection, measurement
of intervention, departures from intended interventions,
missing data, measurement in outcomes and selection
of the reported result in included non-randomised
studies will be assessed using the ROBINS-I tool [14]
(see https://sites.google.com/site/riskofbiastool/). Each
study will be rated as critical, serious, moderate or
low risk of bias based on a judgement of the gathered
information. If there is insufficient detail reported in
the study, the risk of bias will be classified as ‘no
information’ and the original study authors will be
contacted for more information. Reporting of infor-
mation on the flow of participants through the trial
(e.g. from a Consolidated Standards of Reporting
Trials (CONSORT) diagram) will be recorded.
Data on risk of bias will be presented in an additional
table for all included studies, and results will be inter-
preted in light of risk of bias; studies will not be
excluded on the grounds of risk of bias. Where it is ap-
propriate to do a meta-analysis, risk of bias will be in-
cluded in the GRADE assessment of study limitations.
Data extraction
A data extraction form will be developed to collect the
outcome measures given under the ‘Types of outcome
measures’ section. Data will be extracted from each art-
icle by two authors independently. Disparities in data ex-
traction will be resolved through discussion and, if
necessary, the involvement of a third reviewer. We will
contact the authors of reports of potentially relevant
studies to try and obtain information or additional data
needed for the review that is not available in the pub-
lished reports. Data will be extracted on the recruitment
intervention evaluated, country in which the study was
conducted, type of population, details on the study set-
ting, description of study to be recruited into and num-
bers and proportions recruited using each intervention
and comparator.
Data synthesis
Trials will be analysed according to the type of interven-
tion used in the study (e.g. newspaper articles, use of
SMS reminders); interventions will be grouped when
their form or content is deemed sufficiently alike. A fur-
ther categorisation by type of participant will be used if
we find the same intervention applied to more than one
type of participant (e.g. patients, staff at recruiting
centres).
Dealing with missing data
Attempts will be made to contact study authors to ob-
tain any missing data (e.g. participant, intervention or
outcome details). Analyses will be conducted on an
intention-to-treat basis where possible; alternatively, data
will be analysed as reported. Loss to follow-up will be re-
ported and assessed as a potential source of bias in our
risk of bias assessment.
Assessment of heterogeneity
The likely nature of the included studies means that we
anticipate that much of the analysis will be narrative de-
scription of the data rather than a statistical analysis,
which we intend to present in tables, grouped by
intervention type (and possibly participant if the same
intervention is used with different types of partici-
pant). Where population, intervention and outcome
are sufficiently similar to allow pooling of data in a
meta-analysis, we will look for both visual evidence of
heterogeneity in forest plots and statistical evidence
of heterogeneity using the chi-square test for hetero-
geneity and the degree of heterogeneity quantified
using the I2 statistic [14]. Where substantial hetero-
geneity is detected (I2 ≥ 50 %), possible explanations
will be investigated informally and the data sum-
marised using a random-effects model if appropriate.
Assessment of reporting bias
We will investigate reporting (publication) bias for the
primary outcome using a funnel plot where 10 or more
studies of the same population, intervention and out-
come are available. Care will be taken when interpreting
any asymmetry in the funnel plots as this is not always
due to publication bias.
Confidence in cumulative estimate
Where possible, we will pool studies and apply the
GRADE approach to give an overall assessment of the
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certainty of the evidence [10, 15]. Certainty will be
considered either as high (further research is very
unlikely to change our confidence in the estimate of
effect), moderate (further research is likely to have an
important impact on our confidence in the estimate
of effect and may change the estimate), low (further
research is very likely to have an important impact
on our confidence in the estimate of effect and is
likely to change the estimate) or very low (very un-
certain about the estimate of effect). Two authors will
independently apply GRADE to assess the certainty of
the evidence.
Discussion
This review will summarise the evidence on the
effectiveness of recruitment interventions evaluated in
non-randomised studies. To the best of our know-
ledge, this is the first systematic review to attempt to
collate what is likely to be a substantial body of re-
search. This lack of collation has meant that these
studies are essentially lost to trialists when developing
their recruitment strategies. We are under no illu-
sions with regard to the likely quality of many or
most of these studies for estimating effect; it is likely
to be low or very low. However, there are so many of
these studies that we are reasonably optimistic that
we will be able to pool some studies, apply GRADE
and find encouraging results for at least some inter-
ventions, which if not sufficiently strong in their own
right may nevertheless suggest interventions worth
evaluating in future randomised studies. It is also
worth remembering that high-quality evidence from
randomised evaluations of trial recruitment interven-
tions is currently extremely sparse, which is remark-
able given how central recruitment is to trial success
[9]. Whilst it may seem like a good idea to combine
this review with the Cochrane review of randomised
evaluations of recruitment strategies [9], there is a
possibility that the outcome of this review is to make
clear that non-randomised evaluations are of little
use. Should this be the case, the time and effort of
doing a combined review now cannot be justified.
However, and if appropriate, the two reviews may be
combined in the future to produce a full review of re-
cruitment strategies encompassing both randomised
and non-randomised evaluation methods.
The results of this review will add to the current evi-
dence base to inform trialists of the most effective
methods to recruit participants and will inform
researchers of the value (good or bad) of attempting to
evaluate interventions in non-randomised ways.
This work is part of the Trial Forge initiative [16] to
improve trial efficiency.
Additional file
Additional file 1: PRISMA-P 2015 checklist. The PRISMA framework will
be used to ensure the transparent reporting of this systematic review
including the flow diagram. (DOC 99 kb)
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